Skip to main content
Anatolian Journal of Cardiology logoLink to Anatolian Journal of Cardiology
. 2018 Aug;20(2):134.

Author`s Reply

Shokoufeh Hajsadeghi 1, Mohammad Hossein Rahbar 1, Aida Iranpour 1,, Ali Salehi 1, Omolbanin Asadi 2, Scott R Jafarian 3
PMCID: PMC6237959  PMID: 30088491

To the Editor,

We all know that a unifying explanation about the mechanism of takotsubo cardiomyopathy (TTS) remains questionable, but the main explanation is the overstimulation of beta 1 receptors in the heart (no difference between myocardium and endocardium) due to catecholamine surge. This phenomenon leads to microcirculatory dysfunction and direct cardiotoxicity, which results in severe myocardial morphological alterations (1). The observed alterations occur as myocardial histological changes, including focal mononuclear inflammatory areas of fibrotic response and characteristic contraction bands.

Based on observations in our patient and the literature review, a phase of hypercontractility preceding the stage of regional wall motion abnormalities is noted in most patients.

Observations of reverse and mid-ventricular types of TTS in younger patients have raised questions about the underlying mechanisms for us too, but further studies and literature review are needed to clarify the exact explanation.

Reference

  • 1.Hajsadeghi S, Rahbar MH, Iranpour A, Salehi A, Asadi O, Jafarian SR. Dobutamine-induced takotsubo cardiomyopathy: A systematic review of the literature and case report. Anatol J Cardiol. 2018;19:412–6. doi: 10.14744/AnatolJCardiol.2018.78642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Anatolian Journal of Cardiology are provided here courtesy of Turkish Society of Cardiology

RESOURCES